⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Class Action Alert: Levi & Korsinsky Reminds Regeneron (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for Investors
prnewswire.com
REGN
Join Class Action to Recover Losses from Regeneron Pharmaceuticals, Inc. (REGN) – Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regeneron (REGN) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
REGN
REGN ALERT: Hagens Berman Alerts Regeneron Pharmaceuticals, Inc. (REGN) Investors to Pending Securities Class Action Amid Disclosures About Key Trial’s Protocol and Ultimate Failure
globenewswire.com
REGN
REGN LAWSUIT ALERT: Levi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors - Lead Plaintiff Deadline September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Alerts Shareholders to Investor Suit Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Securities Lawsuit Alert: Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
$REGN Notification: Regeneron Investors That Suffered Losses After 9% Stock Drop Are Notified of Upcoming September 14 Deadline in Securities Class Action
accessnewswire.com
REGN
Class Action Lawsuit Filed: Regeneron Pharmaceuticals, Inc. (REGN) - Join by September 14, 2026 - Contact Levi & Korsinsky
accessnewswire.com
REGN